Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma.

They say beauty lies in the eyes of the beholder, but what happens when the beholder’s eyes are too dry, strained, and glassy ...

University of Missouri researchers have discovered two potential biomarkers of glaucoma – agmatine and thiamine ...

A research team at the University of Missouri has made a discovery that could transform how glaucoma is detected and treated. Glaucoma, a major cause ...

Learn all about chronic migraine: its diagnosis, symptoms, risk factors, and effective treatments. Discover lifestyle ...

Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers and severe pain for six years. She ...

What are called autoimmune diseases can affect just about every part of the body – and tens of millions of people. While most ...

The sport's links to the disease are unproven but it has left a traumatic legacy in affecting so many high-profile players ...

UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy is safe and effective across all subtypes.

Gadolinium-enhanced delayed inner ear magnetic resonance imaging (MRI) improves diagnostic accuracy for Meniere disease (MD) ...

A newly identified disorder, MINA syndrome, results from a mutation in the NAMPT protein that deprives motor neurons of ...

Current treatment options have been limited to symptom control. Telitacicept, a novel fusion protein, and ianalumab, a monoclonal antibody, demonstrate improvement in disease activity.